Jonathan Arias

J. Arias is a researcher in biomedicine and biotechnology. Co-founder of Bright and scientist at the University of Oslo. His research interests include cell therapy, gene therapy, stem cells, genome engineering, immunotherapy and artificial intelligence driven biosciences.

He currently leads a project investigating novel cell-based therapeutics including chimeric antigen receptors (CAR), natural killers (NK) and designer nucleases, which is supported by Marie Skłodowska Curie – Scientia.